GE HealthCare: Broad-Based Growth Makes The Bull Case More Compelling

GE HealthCare Technologies delivered strong 3Q26 results, with broad-based demand, 6.2% organic revenue growth, and meaningful margin expansion. Pharmaceutical Diagnostics and Flyrcado offer attractive growth, while the SOFIE acquisition should strengthen radiopharmaceutical capabilities and future revenue streams. Raised 2026 outlook: organic revenue growth to 4%, adjusted EPS to $4.95–$5.05, and free cash flow to at least $1.6 billion.

Seeking Alpha • 14 hours ago

GEHC vs. HAE: Which Stock Is the Better Value Option?

Investors with an interest in Medical - Products stocks have likely encountered both GE HealthCare Technologies (GEHC) and Haemonetics (HAE). But which of these two stocks is more attractive to value investors?

Zacks Investment Research • 7 hours ago

GE HealthCare Stock Eyes Breakout On Best Earnings Since Spinoff

GE HealthCare separated from General Electric and began trading under GEHC in 2023.

Investors Business Daily • Oct 28, 2026

GE HealthCare Technologies Q3 Earnings Call Highlights

GE HealthCare Technologies NASDAQ: GEHC reported third-quarter 2026 revenue growth across all of its business segments, supported by demand in imaging and pharmaceutical diagnostics, improved execution in patient care products and margin expansion.

MarketBeat • 21 hours ago

GE HealthCare Technologies Inc. (GEHC) Q3 2026 Earnings Call Transcript

GE HealthCare Technologies Inc. (GEHC) Q3 2026 Earnings Call Transcript

Seeking Alpha • Oct 28, 2026

GE HealthCare reports third quarter 2026 financial results

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today reported financial results for the third quarter ended September 30, 2026. GE HealthCare President and CEO Peter Arduini said, “We delivered strong top-line growth and margin expansion across all segments, and robust EPS growth in the third quarter. This reflects our teams' commercial execution, disciplined operational focus enabled by Heartbeat, and continued customer adoption of our innovations. With our improved performance year-to.

Business Wire • Oct 28, 2026

GE HealthCare Lifts Forecasts on Healthy Hospital Spending

GE HealthCare Technologies Inc. (NASDAQ:GEHC) shares rose Wednesday after the company reported third-quarter results that topped Wall Street estimates.

Benzinga • Oct 28, 2026

GE HealthCare Technologies (GEHC) Q3 Earnings and Revenues Beat Estimates

GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.34 per share, beating the Zacks Consensus Estimate of $1.21 per share. This compares to earnings of $1.07 per share a year ago.

Zacks Investment Research • Oct 28, 2026

Compared to Estimates, GE HealthCare (GEHC) Q3 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for GE HealthCare (GEHC) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Investment Research • Oct 28, 2026

GEHC Q3 Earnings Beat Estimates on Strong Growth, '26 View Raised

GE HealthCare's Q3 earnings and revenues beat estimates on strong segment growth and higher margins, driving raised 2026 guidance as shares gain 8.3%.

Zacks Investment Research • Oct 28, 2026